XT
LEXX icon

XTX Topco’s Lexaria Bioscience LEXX Stock Holding History

XTX Topco’s Portfolio LEXX Stock Details LEXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.5K Sell
1,487
-184
-11% -$1.99K ﹤0.01% 3995
2026
Q1 		$19.6K Buy
+1,671
New +$18.2K ﹤0.01% 3553
2024
Q4 		– Sell
-1,242
Closed -$56.8K – 2646
2024
Q3 		$56.8K Buy
1,242
+402
+48% +$19.2K ﹤0.01% 1676
2024
Q2 		$35K Buy
840
+155
+23% +$6.97K ﹤0.01% 1546
2024
Q1 		$37.3K Buy
+685
New +$26.2K 0.01% 1515

Other funds holding LEXX

ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

XTX Topco's LEXX Position: Q2 2026 in Review

XTX Topco reduced its Lexaria Bioscience (LEXX) stake by 11% in Q2 2026, selling an estimated $1.99K and leaving 1,487 shares worth $12.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3995.

XTX Topco first reported a position in LEXX in Q1 2024 and has held it in 5 quarters since. The position peaked at $56.8K in Q3 2024. 29 funds tracked by Wall St. Rank hold LEXX as of Q2 2026.

  • XTX Topco held 1,487 shares of Lexaria Bioscience worth $12.5K as of Q2 2026.
  • XTX Topco sold 184 Lexaria Bioscience shares in Q2 2026, an estimated $1.99K.
  • Lexaria Bioscience made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #3995 holding.
  • XTX Topco first reported a position in Lexaria Bioscience in Q1 2024 and has held it in 5 quarters since.
  • XTX Topco's Lexaria Bioscience position peaked at $56.8K in Q3 2024.
  • 29 funds tracked by Wall St. Rank held Lexaria Bioscience as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.